ProPhase Labs, Inc. Accrued Bonuses, Current
ProPhase Labs, Inc. (PRPH) had Accrued Bonuses, Current of $0 as of 2024-12-31, per its 10-K filed 2025-04-01.
Financial Statements › Notes › Payables and Accruals › Accrued Liabilities, Current › Employee-related Liabilities, Current
us-gaap:AccruedBonusesCurrent · last filed 2025-04-01
- 2024-12-31: Accrued Bonuses, Current $0.00.
- 2023-12-31: Accrued Bonuses, Current $1.00M.
- 2022-12-31: Accrued Bonuses, Current $0.00.
- 2017-03-31: Accrued Bonuses, Current $1.87M.
| Period end | Accrued Bonuses, Current |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-04-01 |
| 2023-12-31 | $1.00M 10-K · filed 2025-04-01 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-29 |
| 2017-03-31 | $1.87M 10-Q/A · filed 2018-08-20 |
| 2016-12-31 | $170.00K 10-Q/A · filed 2018-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |